Berita

Affordability and Access: Why patient perspectives matter

“Context around patient-identified affordability and access challenges is really...

Regulatory Demands for More Process Control Data Fuelin...

Advances in technology are making it easier for biopharma companies to embrace c...

Bicistornic Vectors + piggyBac = Improved Antibody Cell...

To produce stable cell lines for monoclonal antibody production, manufacturers t...

The DNA Balancing Act in Boosting Bacterial Productivity

A new mathematical model tracks how plasmids move through competing E. coli popu...

New Spectrometry Technique Could Aid Formulation Develo...

A new spectrometry technique could help companies better understand what happens...

How physicians think AI will boost productivity, compen...

A new survey found that about one-quarter of physicians think that AI will boost...

Andelyn to Support Manufacturing Scaleup for Genprex’s ...

Under the agreement, Andelyn will transition Genprex's adeno-associated virus (A...

TraceIQ Launched to Maximize Pharmaceutical Traceability

TraceIQ, which was developed and being marketing by Systech, combines enterprise...

Single-Cell Striatum Atlas Reveals Neurological Disorde...

Researchers generated a single-cell atlas of the striatum, identifying 31 neuron...

Advanced Imaging Technique Reveals Immune Cell Metaboli...

Researchers showed how optical metabolic imaging (OMI) can be used to characteri...

Lilly Looks Beyond Obesity with Up-to-$2.9B Acquisition...

Based in Cambridge, MA, Merida develops biologic drugs that are engineered to se...

Derm Deep Dive: What is Basal Cell Carcinoma?

What You Need to Know About Basal Cell Carcinoma and Why Early Detection and Tre...

Single-Use Comes of Age—What’s Next?

Single-use systems (SUS) bioprocessing technology has become mainstream. But the...

Single-Use Comes of Age—What Comes Next?

Single-use systems (SUS) bioprocessing technology has become mainstream. But the...

Spatial Transcriptomics Tools May Link Tumor Organizati...

A new spatial transcriptomics framework compares tumor “floor plans." In a study...

BIO 2026: Are we entering the ‘golden era’ of women’s h...

For years, advocates have pushed for more research and investment in women’s hea...